rebimastat (BMS-275291) / BMS - LARVOL DELTA

Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 M Protease. (PubMed, Molecules) - "Our results indicate that levothyroxine, amobarbital and ABP-700 are the best potential inhibitors of the SARS-CoV-2 virus through their binding to the M enzyme. Five other compounds showed also a negative but small free energy of binding: nikethamide, nifurtimox, rebimastat, apomine and rebastinib."

Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases